In this expert-led webinar, we unpack the critical changes reshaping the future of diagnostic laboratories in the U.S.
From upcoming Medicare CLFS cuts and Medicaid shakeups to the accelerating pace of digital pathology adoption, this session offers strategic insights every lab leader needs.
You’ll discover:
✅ What the end of the PAMA rate freeze means for your lab
✅ How labs are playing offense vs. defense with reimbursement
✅ The ROI of digitizing slides—and how to align your team around innovation
✅ Key takeaways from the latest Digital Pathology Survey
✅ How to prepare now for 2026’s reimbursement updates
🚨 BONUS: Learn how NovoPath’s workflow assessment helps labs identify automation opportunities, align stakeholders, and build a clear path to ROI.
Want to see NovoPath’s premeir LIS in action? Find a time to meet with our team here.
